Hot Pursuit     25-Apr-23
Meghmani Finechem slumps after Q4 PAT drop 23% YoY
Meghmani Finechem tumbled 4.99% to Rs 992.80 after the company's consolidated net profit declined 23% to Rs 76.73 crore in Q4 FY23 from Rs 99.18 crore in Q4 FY22.

Revenue from operations increased by 13% YoY to Rs 562.17 crore in the fourth quarter.

Total expenses increased by 28% YoY to Rs 456.63 crore during the period under review, due to higher raw material costs (up 53% YoY), higher depreciation and amortisation expense (up 43% YoY) and higher finance costs (up 61% YoY).

Profit before tax in Q4 FY23 stood at Rs 110.06 crore, down by 24% from Rs 144.19 crore in Q4 FY22.

The company's consolidated net profit increased by 40% to Rs 353.29 crore on a 41% rise in revenue from operations to Rs 2,188.39 crore in FY23 over FY22.

Meghmani Finechem (MFL) is an integrated manufacturer of chemicals in India. The company is India's 4th largest manufacturer of caustic soda, chlorine and hydrogen and a leading manufacturer of caustic potash, chloromethanes and hydrogen peroxide. MFL is further expanding into chlorotoluene & its value chain to strengthen its position in specialty chemical segment.

Previous News
  Meghmani Finechem standalone net profit rises 142.13% in the March 2021 quarter
 ( Results - Announcements 21-May-21   07:39 )
  Epigral announces board meeting date
 ( Corporate News - 16-Jul-24   17:34 )
  Meghmani Finechem receives upgrade in LT credit ratings
 ( Corporate News - 02-Dec-21   16:49 )
  Meghmani Finechem to convene AGM
 ( Corporate News - 30-Aug-21   10:21 )
  Meghmani Finechem partners with Renew Green Energy
 ( Corporate News - 28-May-22   14:18 )
  Meghmani Finechem hits record high after robust Q4 earnings
 ( Hot Pursuit - 26-Apr-22   12:37 )
  Epigral edges higher after commissioning 45,000 TPA CPVC resin capacity at Dahej
 ( Hot Pursuit - 03-Apr-24   13:09 )
  Shares of Meghmani Finechem get listed
 ( Corporate News - 18-Aug-21   09:16 )
  Meghmani Finechem awarded Responsible Care Certification by ICC
 ( Corporate News - 16-Mar-21   10:14 )
  Epigral to conduct AGM
 ( Corporate News - 13-Jun-24   17:40 )
  Epigral to hold board meeting
 ( Corporate News - 02-Jan-24   15:27 )
Other Stories
  IndusInd Bank PAT rises to Rs 2,152 cr in Q1 FY25
  26-Jul-24   17:40
  Cipla spurts as Q1 PAT rises 18% YoY to Rs 1,178 cr
  26-Jul-24   15:53
  Shriram Finance soars as Q1 PAT rises 18% YoY
  26-Jul-24   15:33
  Indus Towers spurts on buyback plan
  26-Jul-24   15:28
  MMTC Ltd leads losers in 'A' group
  26-Jul-24   15:00
  Nova Agritech Ltd leads losers in 'B' group
  26-Jul-24   14:45
  Volumes soar at New India Assurance Company Ltd counter
  26-Jul-24   14:30
  Piramal Pharma Q1 net loss narrows to Rs 89 crore
  26-Jul-24   14:28
  Mphasis spurts as Q1 PAT rises 3% QoQ to Rs 405 cr
  26-Jul-24   14:10
  Go Digit General Insurance gains after PAT rises 74% YoY to Rs 101 cr in Q1 FY25
  26-Jul-24   13:25
Back Top